JP2009544279A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544279A5 JP2009544279A5 JP2009516822A JP2009516822A JP2009544279A5 JP 2009544279 A5 JP2009544279 A5 JP 2009544279A5 JP 2009516822 A JP2009516822 A JP 2009516822A JP 2009516822 A JP2009516822 A JP 2009516822A JP 2009544279 A5 JP2009544279 A5 JP 2009544279A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- polypeptide
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims 8
- 229920001184 polypeptide Polymers 0.000 claims 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 241000605862 Porphyromonas gingivalis Species 0.000 claims 4
- 208000028169 periodontal disease Diseases 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 108090000623 proteins and genes Proteins 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 230000000890 antigenic effect Effects 0.000 claims 3
- 241000283690 Bos taurus Species 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000002452 interceptive effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 241000282472 Canis lupus familiaris Species 0.000 claims 1
- 241000283086 Equidae Species 0.000 claims 1
- 241000282326 Felis catus Species 0.000 claims 1
- 241000282412 Homo Species 0.000 claims 1
- 241001494479 Pecora Species 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 244000144977 poultry Species 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2006903425A AU2006903425A0 (en) | 2006-06-27 | Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease | |
| PCT/AU2007/000890 WO2008000028A1 (en) | 2006-06-27 | 2007-06-27 | Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544279A JP2009544279A (ja) | 2009-12-17 |
| JP2009544279A5 true JP2009544279A5 (enExample) | 2010-09-02 |
Family
ID=38845037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009516822A Pending JP2009544279A (ja) | 2006-06-27 | 2007-06-27 | 歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20100092471A1 (enExample) |
| EP (1) | EP2038297A4 (enExample) |
| JP (1) | JP2009544279A (enExample) |
| AU (1) | AU2007264402B2 (enExample) |
| CA (1) | CA2652957A1 (enExample) |
| WO (1) | WO2008000028A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
| US8129500B2 (en) | 1997-12-10 | 2012-03-06 | Csl Limited | Porphyromonas gingivalis polypeptides and nucleotides |
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| CN103357014A (zh) * | 2007-07-12 | 2013-10-23 | 口腔健康澳洲私人有限公司 | 生物膜治疗 |
| EP2604692A1 (en) | 2007-07-12 | 2013-06-19 | Oral Health Australia Pty Ltd | Immunology treatment for biofilms |
| JP2009173558A (ja) * | 2008-01-22 | 2009-08-06 | Gen Corp:Kk | 抗イヌ歯周病組成物 |
| US8871213B2 (en) | 2008-08-29 | 2014-10-28 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of P. gingivalis infection |
| RU2012107993A (ru) * | 2009-08-02 | 2013-09-10 | Санофи Пастер Лимитид | Полипептиды porhyromonas gingivalis |
| MY162557A (en) | 2010-02-26 | 2017-06-15 | Oral Health Australia Pty Ltd | Treatment or prevention of infection |
| TWI542695B (zh) * | 2010-12-15 | 2016-07-21 | 日星股份有限公司 | 牙周病原菌血漿或血清抗體價檢查套組 |
| US11191665B2 (en) | 2011-02-04 | 2021-12-07 | Joseph E. Kovarik | Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| WO2012173244A1 (ja) * | 2011-06-17 | 2012-12-20 | 国立大学法人東北大学 | 人獣共通感染性歯周病菌検出用マーカー |
| JP6310631B2 (ja) * | 2011-10-18 | 2018-04-11 | サンスター株式会社 | 歯周病原菌血漿または血清抗体価検査キット |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US11672835B2 (en) | 2013-12-20 | 2023-06-13 | Seed Health, Inc. | Method for treating individuals having cancer and who are receiving cancer immunotherapy |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US11529379B2 (en) | 2013-12-20 | 2022-12-20 | Seed Health, Inc. | Method and system for reducing the likelihood of developing colorectal cancer in an individual human being |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11642382B2 (en) | 2013-12-20 | 2023-05-09 | Seed Health, Inc. | Method for treating an individual suffering from bladder cancer |
| US12318377B2 (en) | 2013-12-20 | 2025-06-03 | Seed Health, Inc. | Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| EP4255385A4 (en) * | 2021-01-11 | 2025-03-26 | Keystone Bio, Inc. | ANTIGEN COMPOSITION(S) AND METHOD(S) AGAINST PORPHYROMONAS GINGIVALIS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIONS AND/OR DISEASES |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210035A (en) * | 1980-05-19 | 1993-05-11 | Board Of Trustees Of Leland Stanford Jr. University | Non-reventing live vaccines |
| US4837151A (en) * | 1980-05-19 | 1989-06-06 | The Board Of Trustees Of The Leland Stanford Junior University, Stanford University | Live vaccines comprising two mutations and foreign antigen |
| US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
| US4603112A (en) * | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US5830710A (en) | 1988-09-08 | 1998-11-03 | University Of Florida | Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| WO1994027606A1 (en) | 1993-05-28 | 1994-12-08 | Unisearch Limited | Method of treating helicobacter pylori infection |
| US5711937A (en) | 1993-06-28 | 1998-01-27 | Lion Corporation | Oral composition |
| US6017532A (en) | 1993-09-10 | 2000-01-25 | University Of Georgia Research Foundation, Inc. | Porphyromonas gingivalis arginine-specific proteinase |
| US5475097A (en) | 1993-10-21 | 1995-12-12 | University Of Georgia Research Foundation, Inc. | Lysine-specific Porphyromonas gingivalis proteinase |
| US5523390A (en) | 1993-09-10 | 1996-06-04 | University Of Georgia Research Foundation, Inc. | Porphyromonas gingivalis arginine-specific proteinase |
| EP0717747B1 (en) | 1993-09-10 | 2003-06-04 | The University Of Georgia Research Foundation, Inc. | Porphyromonas gingivalis arginine-specific proteinase coding sequences |
| JPH0797395A (ja) | 1993-09-28 | 1995-04-11 | Kyowa Medex Co Ltd | ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途 |
| EP0753577B1 (en) | 1994-03-29 | 2002-07-24 | Kyowa Hakko Kogyo Co., Ltd. | Cell-surface polypeptide gene |
| AUPN627595A0 (en) | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| AU742668B2 (en) | 1996-03-22 | 2002-01-10 | Morehouse School Of Medicine | Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| AUPN901296A0 (en) * | 1996-03-29 | 1996-04-26 | University Of Melbourne, The | Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| US7341727B1 (en) * | 1996-05-03 | 2008-03-11 | Emergent Product Development Gaithersburg Inc. | M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same |
| AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
| EP2264176A1 (en) * | 1997-12-10 | 2010-12-22 | CSL Limited | Porphorymonas gingivalis polypeptides and polynucleotides |
| AUPP083997A0 (en) | 1997-12-10 | 1998-01-08 | Csl Limited | Porphyromonas gingivalis nucleotides |
| US8129500B2 (en) | 1997-12-10 | 2012-03-06 | Csl Limited | Porphyromonas gingivalis polypeptides and nucleotides |
| US6444799B1 (en) | 1997-12-31 | 2002-09-03 | Csl Limited | P. gingivalis polynucleotides and uses thereof |
| AUPP893999A0 (en) * | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
| GB9913437D0 (en) | 1999-06-09 | 1999-08-11 | Medical Res Council | Fusion proteins |
| AUPQ485999A0 (en) | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| AUPQ718200A0 (en) | 2000-04-28 | 2000-05-25 | Csl Limited | Porphyromonas gingivalis recombinant proteins and truncations |
| US6576226B1 (en) | 2000-11-17 | 2003-06-10 | Gary R. Jernberg | Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease |
| GB2381449A (en) | 2001-10-31 | 2003-05-07 | Smithkline Beecham Plc | Oral hygiene compositions comprising an electron acceptor |
| DK1660524T3 (da) | 2003-08-15 | 2011-05-09 | Univ Florida | Identifikation af porphyromonas gingivalis virulens polynukleotider til diagnose, behandling, og monitorering af periodontale sygdomme |
| EP1721283B1 (en) * | 2004-02-06 | 2022-11-30 | Council of Scientific and Industrial Research | Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential |
| WO2006032104A1 (en) | 2004-09-23 | 2006-03-30 | The University Of Melbourne | Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection |
| WO2008016385A2 (en) | 2006-01-20 | 2008-02-07 | The University Of Washington | Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof |
| WO2008124646A2 (en) | 2007-04-06 | 2008-10-16 | The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services | Use of amyloid proteins as vaccine scaffolds |
| CN103357014A (zh) | 2007-07-12 | 2013-10-23 | 口腔健康澳洲私人有限公司 | 生物膜治疗 |
| EP2604692A1 (en) | 2007-07-12 | 2013-06-19 | Oral Health Australia Pty Ltd | Immunology treatment for biofilms |
| US8871213B2 (en) | 2008-08-29 | 2014-10-28 | Oral Health Australia Pty Ltd | Prevention, treatment and diagnosis of P. gingivalis infection |
| US20110104179A1 (en) | 2009-06-19 | 2011-05-05 | Oral Health Australia Pty Ltd | Protease inhibitory peptides |
-
2007
- 2007-06-27 CA CA002652957A patent/CA2652957A1/en not_active Abandoned
- 2007-06-27 EP EP07719129A patent/EP2038297A4/en not_active Ceased
- 2007-06-27 JP JP2009516822A patent/JP2009544279A/ja active Pending
- 2007-06-27 AU AU2007264402A patent/AU2007264402B2/en not_active Ceased
- 2007-06-27 US US12/306,495 patent/US20100092471A1/en not_active Abandoned
- 2007-06-27 WO PCT/AU2007/000890 patent/WO2008000028A1/en not_active Ceased
-
2012
- 2012-07-12 US US13/547,556 patent/US8916166B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544279A5 (enExample) | ||
| Abbas et al. | IgY antibodies for the immunoprophylaxis and therapy of respiratory infections | |
| Marquardt et al. | Antimicrobial resistance in livestock: advances and alternatives to antibiotics | |
| McNeilly et al. | Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157: H7 following oral challenge | |
| WO2008076915A3 (en) | Treatment of pigs with pcv2 antigen | |
| JP2009537143A5 (enExample) | ||
| KR101484025B1 (ko) | 염증성 질환의 치료를 위한 ｃｘｃｌ１３ 길항제 및 이의 용도 | |
| JP2010516290A5 (enExample) | ||
| JP2008507531A5 (enExample) | ||
| JP2011524343A5 (enExample) | ||
| JP2008538183A5 (enExample) | ||
| JP2013501007A5 (enExample) | ||
| EA200970131A1 (ru) | Миметические антитела для glp-1 человека, композиции, способы и применения | |
| JP2019506175A5 (enExample) | ||
| JP2016513956A5 (enExample) | ||
| Yin et al. | Purification and functional characterization of serum transferrin from Nile tilapia (Oreochromis niloticus) | |
| JP2018527405A5 (enExample) | ||
| EP3184120B1 (en) | Emulsified vaccine to obtain formulations of concentrated igy immunoglobulins; processes and uses for the same. | |
| US20200040067A1 (en) | Anti-salmonella antibodies and uses thereof | |
| JP2017502651A5 (enExample) | ||
| JP2019514971A5 (enExample) | ||
| JP2009538344A5 (enExample) | ||
| JP2018511303A5 (enExample) | ||
| JP2006504619A (ja) | 標的因子の特異的食作用のための多機能複合体 | |
| Lee et al. | Superior protective efficacy of genotype IVa-based single-cycle viral hemorrhagic septicemia virus (VHSV) vaccine compared to formalin-killed VHSV vaccine against VHSV genotype Ia in rainbow trout (Oncorhynchus mykiss) |